申请人:SmithKline Beecham Corporation
公开号:US06653310B2
公开(公告)日:2003-11-25
This invention relates to novel compounds and compositions thereof, useful in the treatment of disease states mediated by the chemokine, Interleukin-8 (IL-8).
本发明涉及新化合物及其组合物,可用于治疗由
趋化因子白细胞介素-8(IL-8)介导的疾病状态。